🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference bit.ly/3P5JA7U

Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress bit.ly/467XAoZ

Encouraging Rigosertib Data Presented at EADV as Late Breaker bit.ly/3FawnGp

Promising Preclinical Narazaciclib Data Presented at MCL Meeting bit.ly/3Qo7MUL

Onconova Expands Leadership Team with Two Key Appointments bit.ly/3s368P1

#EBAwarenessWeek is Oct 25-31! Onconova Therapeutics support the thousands living with #EpidermolysisBullosa (EB), a painful, often fatal, and always debilitating rare connective tissue disorder. Learn more at debra.org/ebweek

Onconova Therapeutics’ ASH Poster To Focus on Narazaciclib in MCL investor.onconova.com/events-and-pre…

Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023 bit.ly/3SxUNBC

Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results bit.ly/3QXUZsl

Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference bit.ly/49W1tj2

Meena Arora (Vice President Global Medical Affairs and R&D) and Dr Victor Moyo (Chief Medical Officer) are pleased to attend the San Antonio Breast Cancer Symposium (SABCS 2023)! Pls use [email protected] to connect with them.

Dr Steve Fruchtman (CEO), Dr Victor Moyo (CMO) and Meena Arora (VP Global Medical Affairs and R&D) are proud to be at the 65th American Society of Haematology (ASH) in San Diego. Please reach out at [email protected] if you would like to connect!

The Onconova Management Team will be participating in the 13th Annual LifeSci Partners Corporate Access Event in San Francisco on January 8-9, 2024. Register using the link below to request an in-person meeting with us: lifescievents.com/event/cae2024/

Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024 bit.ly/3T6qq3S

Meena Arora (VP Global Medical Affairs & R&D) and Dr Victor Moyo (Chief Medical Officer) are pleased to be at the 25th European Congress on Gynaecological Oncology in Barcelona. If you would like to connect in Barcelona, please email us at [email protected]

Apr 2, 2024 Onconova Therapeutics, Inc. And Trawsfynydd Therapeutics, Inc. Announce Business Combination To Form Traws Pharma, Inc, A Best-In-Class Virology And Oncology Company investor.onconova.com/news-releases/…